BI

Biolinq

8 known investors

biolinq.com ↗

Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device. It uses an on-device LED light system to signal glucose levels in real time and pairs with a mobile app that provides personalized health insights and trend tracking.

Founders & leadership

JT

Jared TangneyinFounder

RY

Rich Yangin

Investors · 8

AB

Able PartnersNew York City · $500K – $3M

AL

Alpha Wave GlobalMiami

AP

Aphelion Capital

AV

Averin CapitalNew York

BO

BOLD LongevityBoston

HI

Hikma VenturesLondon · $5M

M

M VenturesLos Angeles · $10.8M

RI

RiverVest Venture PartnersSt. Louis · $500K – $3M

In the news

FDA clears Biolinq's color-coded sensor patch for glucose rangesfiercebiotech.com · Sep 2025Biolinq raises $100m for intradermal glucose sensor - Desang Diabetes Servicesdesang.net · May 2025Biolinq Lands $100M Series C - San Diego Business Journalsdbj.com · Apr 2025Biolinq Raises $100Mn in Series C Funding for Wearable Glucose Sensorsdigitalhealthnews.com · Apr 2025Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health - BioSpacebiospace.com · Apr 2025Biolinq Raises $58M in Fundingfinsmes.com · Apr 2024